ARCHIVES

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Plans To Expand CTSU Management Of Clinical Trials.

February 24, 2006

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

How Bypass Budget Says NCI Will Spend Its FY 1984 Money

July 16, 1982

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991